Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.30 |
| ▸ | EEF2K | O00418 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29170101 | 0.81 | L3MBTL1 (0.39) | L3MBTL1CA1CA2HSD11B1SCN9A | |
| SCHEMBL28786609 | 0.81 | L3MBTL1 (0.39) | L3MBTL1SCN9A | |
| SCHEMBL29170087 | 0.79 | L3MBTL1 (0.37) | L3MBTL1CA1CA2HSD11B1SCN9A | |
| SCHEMBL29170142 | 0.78 | L3MBTL1 (0.36) | L3MBTL1HSD11B1SCN9AEEF2K | |
| SCHEMBL29170154 | 0.71 | SCN9A (0.31) | MAPK10HSD11B1SCN9A | |
| SCHEMBL14255710 | 0.70 | EPHX2 (0.40) | — | |
| SCHEMBL29170111 | 0.69 | CXCR2 (0.35) | HSD11B1SCN9A | |
| SCHEMBL22391829 | 0.68 | PKM (0.34) | HSD11B1SCN9A | |
| SCHEMBL29170084 | 0.68 | TTR (0.33) | HSD11B1SCN9A | |
| SCHEMBL28754410 | 0.68 | EGLN2 (0.37) | HSD11B1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117355517-A | Macrocyclic glucagon-like peptide 1 receptor agonists | 伊莱利利公司 | 2024-01-05 | — | — | CN | disclosed |